Form 8-K PHARMACYCLICS INC For: Nov 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Pharmacyclics (PCYC) Tops Q3 EPS by 32c
November 4, 2014 4:39 PM ESTPharmacyclics (NASDAQ: PCYC) reported Q3 EPS of $0.69, $0.32 better than the analyst estimate of $0.37. Revenue for the quarter came in at $307 million versus the consensus estimate of $201.5 million.
For earnings history and earnings-related data on Pharmacyclics (PCYC) click here.
... More